5 Stocks With Bad Sales Growth — SILU DSCO NG PGNX AVEO

Advertisement

This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.

Sprott Resource Lending (AMEX:SILU) specializes in bridge and mezzanine lending to precious and base metals mining, exploration, and development companies and oil and gas companies on a global basis. SILU also gets an F in Analyst Earnings Revisions. The stock has a trailing PE Ratio of 73.3. For more information, get Portfolio Grader’s complete analysis of SILU stock.

Discovery Laboratories (NASDAQ:DSCO) is a biotechnology company focused on developing products for the treatment of respiratory disease. DSCO also gets F’s in Equity and Cash Flow. For more information, get Portfolio Grader’s complete analysis of DSCO stock.

NovaGold Resources (AMEX:NG) explores and develops mineral properties in North America. NG gets F’s in Analyst Earnings Revisions and Equity as well. Since January 1, NG has fallen 27%. For more information, get Portfolio Grader’s complete analysis of NG stock.

Progenics Pharmaceuticals (NASDAQ:PGNX) develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. PGNX also gets F’s in Earnings Growth, Earnings Momentum, Analyst Earnings Revisions, Equity, and Cash Flow. Shares of the stock have declined 60.9% since January 1. This is worse than the Nasdaq, which has seen a 22.1% increase over the same period. For more information, get Portfolio Grader’s complete analysis of PGNX stock.

AVEO (NASDAQ:AVEO) engages in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. AVEO gets F’s in Earnings Momentum, Equity, Cash Flow, and Operating Margin Growth as well. Shares of the stock have declined 37.1% since January 1. For more information, get Portfolio Grader’s complete analysis of AVEO stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2012/09/5-stocks-with-bad-sales-growth-silu-dsco-ng-pgnx-aveo-silu-dsco-ng/.

©2024 InvestorPlace Media, LLC